At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
CentriMag RVAS placementdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CentriMag RVAS U.S. Post-approval Study Protocol
In Brief
A clinical study evaluating CentriMag RVAS placement for Right Ventricular Failure. Completed, enrolled 25 participants across 10 sites.
Detailed Summary
The study objective is to gather post-market clinical data on the use of the CentriMag RVAS when used for temporary mechanical circulatory support of the right ventricle in patients with acute right ventricular failure from any cause
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRight Ventricular Failure
CountriesUnited States
CollaboratorsThoratec Corporation
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2009
First PostedApr 2012
Primary CompletionFeb 2014
Study CompletionJun 2014
TodayJul 2026
First PostedApr 2, 2012
Enrollment StartSep 1, 2009
Primary CompletionFeb 1, 2014
Study CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 14.3 years ago
Interventions
CentriMag RVAS placementdevice
Patients will be treated with a CentriMag RVAS